NTRA
Natera, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #542
- Final score
- 48.88
- Years on list
- 4
↗ Climbed 439 since 2022
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- NTRA· Natera, Inc.
- AVTR· Avantor, Inc.
- INCY· Incyte Corporation
Figure 01 · Side-by-side summary
The headline numbers
AVTR
Avantor, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #519
- Final score
- 49.57
- Years on list
- 6
↗ Climbed 144 since 2020
INCY
Incyte CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #588
- Final score
- 47.04
- Years on list
- 6
↗ Climbed 103 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | NTRA | AVTR | INCY |
|---|---|---|---|
| Climate Change | 57.1 | 57.4 | 64.3 |
| Employee Relations | 40.3 | 45.1 | 60.5 |
| Environment | 55.8 | 46.5 | 42.0 |
| Stakeholders & Society | 35.1 | 55.9 | 34.2 |
| Human Rights | 51.9 | 43.1 | 9.9 |
| Governance | 45.3 | 45.2 | 49.4 |
| Performance Rating | 61.7 | 49.8 | 48.8 |